Please use this identifier to cite or link to this item: https://doi.org/10.1002/jps.20232
DC FieldValue
dc.titleQuantitative structure-pharmacokinetic relationships for drug distribution properties by using general regression neural network
dc.contributor.authorYap, C.W.
dc.contributor.authorChen, Y.Z.
dc.date.accessioned2014-10-28T03:12:32Z
dc.date.available2014-10-28T03:12:32Z
dc.date.issued2005-01
dc.identifier.citationYap, C.W., Chen, Y.Z. (2005-01). Quantitative structure-pharmacokinetic relationships for drug distribution properties by using general regression neural network. Journal of Pharmaceutical Sciences 94 (1) : 153-168. ScholarBank@NUS Repository. https://doi.org/10.1002/jps.20232
dc.identifier.issn00223549
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/104849
dc.description.abstractQuantitative Structure-Pharmacokinetic Relationships (QSPkR) have increasingly been used for developing models for the prediction of the pharmacokinetic properties of drug leads. QSPkR models are primarily developed by means of statistical methods such as multiple linear regression (MLR). These methods often explore a linear relationship between the pharmacokinetic property of interest and the structural and physicochemical properties of the studied compounds, which are not applicable to those agents with nonlinear relationships. Hence, statistical methods capable of modeling nonlinear relationships need to be developed. In this work, a relatively new kind of nonlinear method, general regression neural network (GRNN), was explored for modeling three drug distribution properties based on diverse sets of drugs. The three properties are blood-brain barrier penetration, binding to human serum albumin, and milk-plasma distribution. The prediction capability of GRNN-developed models was compared to those developed using MLR and a nonlinear multilayer feedforward neural network (MLFN) method. For blood-brain barrier penetration, the computed r2 and MSE values of the GRNN-, MLR-, and MLFN-developed models are 0.701 and 0.130, 0.649 and 0.154, and 0.662 and 0.147, respectively, by using an independent validation set. The corresponding values for human serum albumin binding are 0.851 and 0.041, 0.770 and 0.079, and 0.749 and 0.089, respectively, and that for milk-plasma distribution are 0.677 and 0.206, 0.224 and 0.647, and 0.201 and 0.587, respectively. These suggest that GRNN is potentially useful for predicting QSPkR properties of chemical agents. © 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/jps.20232
dc.sourceScopus
dc.subjectBlood-brain barrier
dc.subjectComputational ADME
dc.subjectDistribution
dc.subjectGeneral regression neural network
dc.subjectHuman serum albumin binding
dc.subjectMilk-plasma distribution
dc.subjectPharmacokinetics
dc.typeArticle
dc.contributor.departmentCOMPUTATIONAL SCIENCE
dc.description.doi10.1002/jps.20232
dc.description.sourcetitleJournal of Pharmaceutical Sciences
dc.description.volume94
dc.description.issue1
dc.description.page153-168
dc.description.codenJPMSA
dc.identifier.isiut000226101300017
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.